Induction of hypomagnesemia during amsacrine treatmentSEYMOUR, J. F.American journal of hematology. 1993, Vol 42, Num 3, pp 262-267, issn 0361-8609Article

Response duration and recovery of CD4⁺ lymphocytes following deoxycoformycin in interferon-α-resistant hairy cell leukemia : 7-year follow-upSEYMOUR, J. F; TALPAZ, M; KURZROCK, R et al.Leukemia. 1997, Vol 11, Num 1, pp 42-47, issn 0887-6924Article

Calcitriol : the major humoral mediator of hypercalcemia in Hodgkin's disease and non-Hodgkin's lymphomasSEYMOUR, J. F; GAGEL, R. F.Blood. 1993, Vol 82, Num 5, pp 1383-1394, issn 0006-4971Article

Significant impairment of high-dose methotrexate clearance following vancomycin administration in the absence of overt renal impairmentBLUM, R; SEYMOUR, J. F; TONER, G et al.Annals of oncology. 2002, Vol 13, Num 2, pp 327-330, issn 0923-7534Article

The prognostic significance of auer rods in myelodysplasiaSEYMOUR, J. F; ESTEY, E. H.British journal of haematology. 1993, Vol 85, Num 1, pp 67-76, issn 0007-1048Article

Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemiaFIELD, K; SLAVIN, M. A; SEYMOUR, J. F et al.European journal of haematology. 2002, Vol 69, Num 1, pp 54-57, issn 0902-4441Article

A multicentre retrospective comparison of central nervous system prophylaxis strategies among patients with high-risk diffuse large B-cell lymphomaCHEAH, C. Y; HERBERT, K. E; PRINCE, H. M et al.British journal of cancer. 2014, Vol 111, Num 6, pp 1072-1079, issn 0007-0920, 8 p.Article

Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma NetworkCHEAH, C. Y; GEORGE, A; WALEWSKI, J et al.Annals of oncology. 2013, Vol 24, Num 8, pp 2119-2123, issn 0923-7534, 5 p.Article

Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group studyWIRTH, A; GOSPODAROWICZ, M; SPECHT, L et al.Annals of oncology. 2013, Vol 24, Num 5, pp 1344-1351, issn 0923-7534, 8 p.Article

Patients with chronic myeloid leukemia who maintain a complete molecular response after stopping imatinib treatment have evidence of persistent leukemia by DNA PCRROSS, D. M; BRANFORD, S; MILLS, A. K et al.Leukemia. 2010, Vol 24, Num 10, pp 1719-1724, issn 0887-6924, 6 p.Article

Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study GroupMARTINELLI, G; RYAN, G; TSANG, R et al.Annals of oncology. 2009, Vol 20, Num 12, pp 1993-1999, issn 0923-7534, 7 p.Article

Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphomaCAMPBELL, J. K; MATTHEWS, J. P; SEYMOUR, J. F et al.Annals of oncology. 2003, Vol 14, Num 2, pp 273-276, issn 0923-7534, 4 p.Article

Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phaseBRANFORD, S; RUDZKI, Z; SEYMOUR, J. F et al.Leukemia. 2003, Vol 17, Num 12, pp 2401-2409, issn 0887-6924, 9 p.Article

Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphomaGRIGG, A; BARDY, P; BYRON, K et al.Bone marrow transplantation (Basingstoke). 1999, Vol 23, Num 2, pp 107-110, issn 0268-3369Article

Secondary acute myeloid leukemia with inv(16) : report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapySEYMOUR, J. F; JUNEJA, S. K; CAMPBELL, L. J et al.Leukemia. 1999, Vol 13, Num 11, pp 1735-1740, issn 0887-6924Conference Paper

Clinical correlates of elevated serum levels of interleukin-6 in patients with untreated Hodgkin's diseaseSEYMOUR, J. F; TALPAZ, M; HAGEMEISTER, F. B et al.The American journal of medicine. 1997, Vol 102, Num 1, pp 21-28, issn 0002-9343Article

Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cellsHERBERT, K. E; GAMBELL, P; LINK, E. K et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 3, pp 351-356, issn 0268-3369, 6 p.Article

Liver Transplantation in an Adult With Sclerosing Cholangitis due to Multisystem Langerhans Cell HistiocytosisLEE, R. J; LEUNG, C; LIM, E. J et al.American journal of transplantation (Print). 2011, Vol 11, Num 8, pp 1755-1756, issn 1600-6135, 2 p.Article

A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignanciesBOW, E. J; ROTSTEIN, C; NOSKIN, G. A et al.Clinical infectious diseases. 2006, Vol 43, Num 4, pp 447-459, issn 1058-4838, 13 p.Article

Cardiac involvement in Henoch-Schonlein purpuraPOLIZZOTTO, M. N; GIBBS, S. D. J; BESWICK, W et al.Internal medicine journal (Print). 2006, Vol 36, Num 5, pp 328-331, issn 1444-0903, 4 p.Article

Lack of apoptosis of Sézary cells in the circulation following oral bexarotene therapyBRENNAND, S; SUTTON, V. R; BIAGI, J et al.British journal of dermatology (1951). 2005, Vol 152, Num 6, pp 1199-1205, issn 0007-0963, 7 p.Article

Reversible posterior leukoencephalopathy syndrome complicating cytotoxic chemotherapy for hematologic malignanciesTAM, C. S; GALANOS, J; SEYMOUR, J. F et al.American journal of hematology. 2004, Vol 77, Num 1, pp 72-76, issn 0361-8609, 5 p.Article

Docetaxel effectively mobilizes peripheral blood CD34⁺ cellsPRINCE, H. M; TONER, G. C; WOLF, M et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 5, pp 483-487, issn 0268-3369Article

'Mini-allografts' for haematological malignancies : an alternative to conventional myeloablative marrow transplantationGRIGG, A; SEYMOUR, J. F; ROBERTS, A et al.Australian and New Zealand journal of medicine. 1999, Vol 29, Num 3, pp 308-314, issn 0004-8291Article

Repetitive high-dose therapy with ifosfamide, thiotepa and paclitaxel with peripheral blood progenitor cell and filgrastim support for metastatic and locally advanced breast cancer : Results of a phase I studyPRINCE, H. M; MILLWARD, M. J; JANUSZEWICZ, E. H et al.Annals of oncology. 1999, Vol 10, Num 4, pp 479-481, issn 0923-7534Article